Sign Up to like & get
recommendations!
1
Published in 2022 at "Expert Opinion on Therapeutic Targets"
DOI: 10.1080/14728222.2022.2170781
Abstract: ABSTRACT Introduction Hematological Malignancies (HMs) are a group of progressive, difficult-to-treat, and highly recurrent diseases. A suppressed phenotype of the immune system is present in HMs and growing evidence indicates the role of Cytotoxic T…
read more here.
Keywords:
potentials ctla;
hms;
therapeutic potentials;
prognostic therapeutic ... See more keywords